Evidence-Based Complementary and Alternative Medicine / 2015 / Article / Tab 2

Research Article

Hypocholesterolemic and Antiatherosclerotic Potential of Basella alba Leaf Extract in Hypercholesterolemia-Induced Rabbits

Table 2

Levels of total cholesterol, LDL, triglycerides, and HDL in serum of rabbits from various groups.

G1G2 G3 G4 G5

Total cholesterol (mg/dL)
 Baseline39.45 ± 2.9539.33 ± 3.3844.37 ± 3.8741.41 ± 4.5842.30 ± 4.33
 Week 442.66 ± 2.67472.65 ± 4.54480.83 ± 5.18506.92 ± 9.57467.08 ± 8.35
 Week 846.14 ± 4.061104.98 ± 33.321112.70 ± 28.331002.53 ± 11.511038.85 ± 12.35
 Week 1253.57 ± 2.701326.91 ± 19.47456.56 ± 5.23510.99 ± 8.14475.12 ± 10.94
LDL level (mg/dL)
 Baseline26.48 ± 0.7231.19 ± 0.9725.39 ± 0.4329.02 ± 1.1327.03 ± 0.82
 Week 433.92 ± 0.55426.15 ± 4.52440.66 ± 3.39421.68 ± 3.95435.94 ± 2.57
 Week 838.79 ± 0.771157.09 ± 13.851056.66 ± 15.381001.23 ± 12.401081.04 ± 4.06
 Week 1245.96 ± 1.011259.60 ± 15.43515.83 ± 14.03547.39 ± 12.81539.27 ± 13.05
Triglyceride level (mg/dL)
 Baseline110.13 ± 4.55116.46 ± 3.68106.88 ± 6.28114.39 ± 5.36107.56 ± 7.58
 Week 4132.83 ± 7.84340.63 ± 8.74331.84 ± 4.97349.42 ± 3.41329.74 ± 6.95
 Week 8156.38 ± 8.80654.58 ± 15.16650.96 ± 18.35639.52 ± 16.04661.12 ± 18.81
 Week 12166.03 ± 5.81869.57 ± 15.38384.30 ± 14.63416.14 ± 16.73398.53 ± 10.66
HDL level (mg/dL)
 Baseline45.65 ± 0.75841.53 ± 5.2738.27 ± 0.7146.02 ± 1.1539.83 ± 5.30
 Week 446.94 ± 1.0938.13 ± 5.2837.30 ± 0.7844.31 ± 1.1037.09 ± 5.27
 Week 847.45 ± 1.1534.33 ± 5.1836.37 ± 2.6638.51 ± 3.3535.88 ± 3.92
 Week 1247.25 ± 0.4528.27 ± 7.2147.93 ± 2.5153.78 ± 3.4555.05 ± 1.26

G1: normal control, G2: hypercholesterolemic control, G3: simvastatin-treated (10 mg/kg), G4: B. alba extract-treated (100 mg/kg), and G5: B. alba extract-treated (200 mg/kg). All data are presented as the mean ± SD ( for each group). One-way ANOVA was performed followed by Dunnett’s post hoc test for multiple comparisons. Within a week, values sharing the same superscript letters are not significantly different from each other ( < 0.05).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.